NHS approves earlier use of 'game-changing' ovarian cancer drug
Women in England with advanced ovarian cancer will now have access to a drug that could help halt the progression of their disease much earlier in their course of treatment...
Women in England with advanced ovarian cancer will now have access to a drug that could help halt the progression of their disease much earlier in their course of treatment...
Women who have fewer protective bacteria in the vagina may be at increased risk of developing ovarian cancer, according to new research...
A hospital in Ireland has been reviewing hundreds of test reports for the BRCA gene after a woman was incorrectly told she was not at heightened risk of cancer...
A drug to treat ovarian cancer has shown promising results in a clinical trial, delaying signs of relapse and reducing chances of death. The drug olaparib, a PARP inhibitor, was used in patients with BRCA-mutated advanced ovarian cancer...
Researchers have discovered that the protein responsible for the development of Huntington's disease is highly toxic to cancer cells...
Scientists have identified a new gene for ovarian cancer risk that may be passed down from fathers to their daughters...
Baroness Mary Warnock, patron of the Progress Educational Trust (PET), which publishes BioNews, is to be awarded a major international prize for her work in bioethics...
Scientists have developed a single blood test to detect eight common cancer types and their location of origin within the body...
The blanket screening of all women over 30 for genetic mutations which cause breast and, or ovarian cancer could prevent more cancers and be more cost effective than current approaches, according to a new study...
A new study has found that BRCA gene mutations do not affect the survival rates of breast cancer patients under 40...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.